12 Comments
First generics and authorized generics enter the market differently, with timing playing a crucial role in pricing and competition. Authorized generics, launched by brand companies, often undercut first generics during their 180-day exclusivity window, reducing price drops and undermining the intended incentive of the Hatch-Waxman Act.
Read More